Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The authors studied the HLA profile of 23 white Dutch patients with muscle-specific kinase antibody-positive myasthenia gravis (MuSK Ab+ MG) and found an association with HLA-DR14-DQ5 (odds ratio 8.5; 95% CI 3.9 to 18.7; p = 4.9 x 10(-5)). Fifty-two percent of the patients carried the DR14 allele compared with 5% of the controls (p = 1.0 x 10(-8)). This association between MuSK Ab+ MG and a relatively rare HLA haplotype differs from the previously described association of early-onset acetylcholine receptor Ab+ MG with HLA-B8-DR3.

Original publication

DOI

10.1212/01.wnl.0000218159.79769.5c

Type

Journal article

Journal

Neurology

Publication Date

13/06/2006

Volume

66

Pages

1772 - 1774

Keywords

Adolescent, Adult, Aged, Child, Cohort Studies, DNA Mutational Analysis, Female, Genetic Predisposition to Disease, HLA-DR Antigens, HLA-DR Serological Subtypes, Humans, Male, Middle Aged, Mutation, Myasthenia Gravis, Netherlands, Prevalence, Receptor Protein-Tyrosine Kinases, Receptors, Cholinergic, Risk Assessment, Risk Factors, Statistics as Topic